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Abstract
Introduction and hypothesis There is growing evidence that
pelvic organ prolapse (POP) is at least partly caused by
underlying hereditary risk factors. The aim of our study
was to provide a systematic literature review and meta-
analysis of clinical studies on family history of POP as a
risk factor for POP in individual women.
Methods The databases PubMed and Embase were
searched. Clinical studies reporting on family history of
POP in relation to POP in individual women were included.
Results Sixteen studies were included, of which eight en-
abled us to calculate a pooled odds ratio (OR). The pooled
OR of POP in case of a positive family history of POP was
2.58 (95 % confidence interval 2.12–3.15).
Conclusions Women with POP are substantially more likely
to have family members with the same condition compared
to women without POP. This strengthens the hypothesis that
genetic predisposition plays an important role in the devel-
opment of POP.
Keywords Family . Genetics . Inheritance . Pelvic organ
prolapse . Review
Introduction
Pelvic organ prolapse (POP) is a major health care problem
with prevalence varying from 8 to 41 % [1, 2] and has a
substantial impact on quality of life [3]. Women with POP
symptoms not only experience physical complaints, but also
encounter more problems regarding general health, personal
relationships and sexual function [3].
In order to reduce the number of women developing POP,
it is important to know the possible risk and protective
factors. The aetiology of POP is considered to be multifac-
torial. Research groups investigated a large variety of risk
factors for POP, such as parity [2, 4–11], body mass index
(BMI) [2, 4, 5, 7, 8, 10–13], menopausal state [4, 7–10, 12,
14] and previous hysterectomy [2, 9, 11, 13] with often
conflicting results. One of the reasons for these conflicting
results might be the fact that not all women are equally
susceptible to POP. Some women with multiple risk factors
never develop POP, whereas others with little to no risk
factors develop POP [15], sometimes already at a young
age. Bump and Norton [16] were the first to describe a
model for the development of pelvic floor dysfunctions.
They divided the different risk factors into predisposing
factors (e.g. hereditary factors, collagen distribution), incit-
ing factors (e.g. vaginal delivery), promoting factors (e.g.
obesity) and decompensating factors (e.g. aging).
There is growing evidence that predisposing hereditary
factors are indeed important in the development of POP. For
instance, Buchsbaum et al. [17] found a high rate of con-
cordance between the POP stage of a parous woman and her
nulliparous sister, thereby suggesting a familial predisposi-
tion toward the development of this disorder. Altman et al.
[18] investigated the prevalence of surgical treatment for
POP in both dizygotic and monozygotic female twin pairs,
knowing that dizygotic twins share approximately 50 % of
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their DNA, while monozygotic twins are 100 % identical.
They found that the influence of genetic factors was sub-
stantial, attributing to 40 % of the variation of liability for
POP. Analysis of the familial inheritance pattern of POP was
performed by Jack et al. [19]. They studied ten families of
young women presenting with severe POP. In these families,
POP was transmitted in a dominant fashion with an incom-
plete, but high degree of penetrance, through both maternal
and paternal relatives.
A genetic risk for developing POP in members of affect-
ed families has important implications for clinical practice.
Individual risk assessment for POP and POP recurrence
might have consequences for both preventive strategies
and the choice of (surgical) treatments.
The aim of our study was to provide a systematic litera-
ture review and meta-analysis of clinical studies on family
history of POP as a risk factor for POP in individual women.
Materials and methods
The databases PubMed and Embase were searched in asso-
ciation with a senior librarian up to 1 June 2011. The search
terms used for each database included different terms for
POP, genetics, inheritance and family and are presented in
detail in the Appendices 1 and 2. References of relevant
studies were cross-checked for additional studies. Two
authors (S.L. and K.K.) evaluated all studies independently.
Any disagreement was discussed and resolved in a consen-
sus meeting.
Clinical studies reporting on familial history of POP in a
cohort of women with and without POP were included. In
case a study only provided information on family history in
the POP group, this study was included as an “uncontrolled
study”. Publications reporting on patients with symptoms
other than POP such as incontinence, rectal prolapse, peri-
neal descent, ureterocele and/or urethral prolapse only were
excluded as well as review articles, case reports and studies
reporting on less than ten (index) patients. Different studies
reporting on the same patient cohort were included once.
There were no language restrictions.
In all relevant studies data on study design, study popu-
lation, sample size, analyses for possible confounders, def-
inition of POP, definition of positive family history and
baseline characteristics were collected. The baseline charac-
teristics that were taken into account were age, parity, vag-
inal deliveries, menopausal status, previous surgery for POP,
previous hysterectomy and BMI. Most importantly, data on
positive family history of POP in relation to absence or
presence of POP in the (index) patient were collected. In
case an article did not provide the above-mentioned infor-
mation, authors were asked to supply the data needed within
an acceptable time frame. In case of missing data with
regard to family history in relation to individual POP status,
these data were excluded from final analysis.
The number of patients with a positive family history in
both POP and control groups was used to calculate the crude
odds ratio (OR) of each study. The pooled OR with the 95 %
confidence interval (CI) is presented. The heterogeneity
index (I2) was used to measure the inconsistency between
the studies [20].
Results
Results of the search
The PubMed search revealed 3,531 studies, and the Embase
search revealed an additional 609 studies. No studies were
revealed by cross-checking; 4,085 of these studies could be
excluded on the basis of title and/or abstract. The remaining
55 studies were read by paper. In total 16 studies fulfilled
the inclusion criteria. The reasons for excluding the other 39
studies are indicated in Fig. 1. The (twin) sister studies were
excluded because although these studies evaluated POP in
the (twin) sister, they did not investigate the presence of
POP in all sisters. The results of these studies were therefore
not a reliable representation of the family history.
Study design and participants
In total 4,354 participants were included in this meta-
analysis and review: 2,413 women with POP and 1,941
without POP (Tables 1 and 2). Of the 2,413 cases with
POP, 1,107 could be included in the meta-analysis. The
remaining 1,306 were included as uncontrolled studies.
The 16 included studies consisted of 7 cohort studies and
9 case-control studies (Tables 1 and 2). Four of the case-
control studies were designed as matched case-control stud-
ies, matching for age [21–24], parity [21, 22, 24], meno-
pausal status [22], hospital at which hysterectomy was
performed [22], year of surgery [22], indication [22] and
type of surgery [22]. In two of the nine case-control studies
[23, 25], only the women with POP were asked whether
they had relatives with POP. Therefore, only the women in
the POP group were included for analysis in this review. In
two of the case-control studies [22, 26] the control group
contained some women with previous POP surgery. Since
this could not be regarded as a valid control group, the
studies were classified as uncontrolled. Four cohort studies
[27–30] did not include a control group and only reported
on women with POP. In all other studies both women with
and without POP were asked whether they had a positive
family history of POP. Two studies only included women
with a previous hysterectomy [22, 26].
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Definition of POP
The definition of POP varied between studies (Tables 1
and 2); four studies used the Pelvic Organ Prolapse
Quantification (POP-Q) system of which two defined
POP as POP-Q stage ≥II [21, 27] and one as POP-Q
stage III/IV [8]. One study provided information on all
different POP-Q stages [31]. We decided to choose
POP-Q stage ≥II as a cut-off point. Three studies used
the Baden-Walker halfway scoring system; one defining
POP as Baden-Walker grade 2 [25], one as ≥grade 1
[32] and one as second- or third-degree uterovaginal
prolapse and/or third-degree cystocele [4]. Three other
studies did not mention any classification system but
used the terms “below the hymenal remnants” [22], “≥
grade 2” [23] and uterine prolapse stage II/III [28]
without referring to any grading system. In six studies,
the POP group consisted only of women who had either
undergone POP surgery or were scheduled for it [22,
23, 25–28]. Three of these studies used POP surgery or
vaginal vault surgery as the definition of POP, without
further defining the severity of POP [26, 29, 30]. In
addition three studies used symptoms as assessed with
questionnaires to identify women with POP [7, 24, 33].
Definition of family history
The definition of family history was not homogeneous
throughout the studies either; two studies included both
mother and sisters in the family history [27, 33], one study
included mother and grandmothers [21], one study
mother, grandmothers and sisters [29], two studies only
the mother [4, 7] and two studies all first-degree family
members [8, 30].
Six studies did not specify the degree of relationship [22,
24–26, 28, 31]. A special remark should be made regarding
the study of McLennan et al. [32], as they also included
male and female relatives with a history of hernia. With the
data provided, we were not able to recalculate the number of
women with only family members affected with POP.
Baseline characteristics
Baseline characteristics of the 16 included studies are out-
lined in Tables 1 and 2. Table 1 presents baseline character-
istics of the controlled studies and Table 2 of the
uncontrolled studies.
Statistical power
Only three studies [21, 26, 33] reported that a power anal-
ysis was performed for sample size calculation. The power
calculation of the study of Braekken et al. [21], however,
was based on the expected difference in joint hypermobility.
Confounders
Except for the study of Sewell et al. [31] all individual
studies considered possible confounding factors, either
through statistical analyses or through study design.
Results on family history of POP
The (crude) ORs of the eight controlled studies are pre-
sented in a forest plot (Fig. 2). All but two studies [21, 31]
showed a statistically significant difference in the preva-
lence of positive family history of POP between women
with POP and women without this condition.
Studies identified from electronic database search
PubMed (n = 3531)
Embase (n = 609)
n = 4140
Studies excluded after 
reading title and abstract
n = 4085
Evaluation of full text article
n = 55
Studies included in systematic review
n = 16
Excluded studies n
- Review, clinical opinion or commentary  6
- No outcome measurement of interest 22
- (Twin-)sister study 4
- Positive family history as inclusion criterion  3 
- Same study population used 3    
- Family history only known in  nulliparous 1  
- Total 39
Controlled studies
n = 8
Uncontrolled studies
n = 8
n = number of studies
Fig. 1 Database search flow
chart
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Eight studies [23, 25–30] only investigated family history
in women with POP. Therefore, no OR could be calculated.
The number and percentages of women with a positive
family history in these studies are shown in Table 2.
The overall OR of POP in case of a positive family
history of POP as compared to a negative family history
was 2.58 (95 % CI 2.12–3.15). Note that the study of
McLennan et al. [32] also included male and female rela-
tives with a history of hernia. When excluding this study, the
OR was slightly different (2.54; 95 % CI 2.02–3.20).
Finally, we also calculated the pooled OR, using the
adjusted OR if presented in the individual studies (data not
shown). By using these data, we found that the pooled OR
was lower but still statistically significantly larger than 1.
Results for family history and recurrences of POP
One study [27] analysed risk factors for the recurrence of
POP in 212 women undergoing surgery for symptomatic
POP. After a median follow-up of 24 months (range 1–
84 months), 36 patients (17 %) presented with recurrence
of POP. After correcting for other possible risk factors, such
as age, parity, mode of delivery and BMI, family history was
not found to be a risk factor for the recurrence of POP. Only
preoperative POP-Q stage IV appeared to be associated.
Discussion
Summary of main results
This paper summarizes the available literature on family history
of POP women with and without POP. All but two studies [21,
31] found a statistically significant difference in the prevalence
of positive family history between women with POP and
women without this condition. A meta-analysis of these studies
resulted in a substantially increased risk for POP in case of a
positive family history. In conclusion, there is strong evidence
that women with at least one female family member with POP
have a significantly higher risk of developing POP.
This suggests an underlying genetic susceptibility. Over
recent years, different research groups have been looking for
possible gene candidates, by searching for DNA polymor-
phisms associated with POP. A number of DNA polymor-
phisms associated with POP have been identified so far:
laminin γ1 [34], estrogen receptor α and β [35, 36], pro-
gesterone receptor [37], collagen, type III, alpha 1 [38–41]
and matrix metalloproteinase-9 [42]. However, not all stud-
ies find the same associations. Jeon et al. [40] found that the
GG genotype of the collagen, type III , alpha 1 (COL3A1)
polymorphism was significantly more prevalent among Ko-
rean women with POP, whereas both Kluivers et al. [38] and
Chen et al. [39] concluded that the AA genotype was sig-
nificantly associated with POP in Caucasian and Taiwanese
females, respectively. On the other hand, Martins et al. [41]
found no correlation between the COL3A1 polymorphism
and POP in their population. As was already suggested by
Martins et al. [41], these differences could be explained by
the fact that all studies were performed in ethnically differ-
ent populations, i.e. Korean, Dutch, Taiwanese and Brazil-
ian, with different background risks of POP.
Only one study so far looked at family history and the
risk of recurrence of POP. If there is an underlying heredi-
tary factor causing weaknesses in the pelvic floor, e.g. by
changes in collagen strength, this might lead to impaired
healing properties after surgery and therefore to more recur-
rences. If this is the case, first-line treatment with mesh
material might be indicated for patients with positive family
history. The study of Jeon et al. [27], however, did not find
such an association and only found preoperative POP-Q
stage IV to be a risk factor for recurrence. This last finding
is in line with the study of Salvatore et al. [43], who
confirmed that preoperative stage ≥III was the only risk
factor for recurrences.
Uncontrolled studies
As for the studies not included in the meta-analysis, the
mean percentage of POP patients with a positive family
history was 28 %. This is comparable with the mean
Heterogeneity; Chi2= 6.97, df= 7 (P= 0.43); I2= 0%
Test for overall effect; Z= 9.36 (P< 0.00001)
Abbreviations: M-H, Mantel-Haenszel; Fixed, fixed effect model; 
POP, pelvic organ prolapse; Neg, negative; Pos, positive
Fig. 2 Forest plot of the eight
controlled studies
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percentage of the controlled studies. It is notable that three
of the studies [23, 25, 28] in the uncontrolled group consist
of rather young women less than 40 years of age. One could
hypothesize that when young women develop POP, there
must be an underlying hereditary factor causing early de-
compensation of the pelvic floor. It might therefore be
possible that those young women more often have family
members with POP. The above-mentioned studies, however,
do not show an increase in positive family history among
these young women. This is in contrast with the study of
Shilo et al. [30] that shows a more than fivefold increase in
positive family history among women under the age of
45 years as compared to women above the age of 55.
Strengths and limitations
The strength of this review is that all articles on family
history and POP were taken into account, without any
language limitations. This resulted in a complete overview
of studies in ethnically diverse populations, from the Euro-
pean, Asian and North and South American continents. It is
therefore reasonable to suggest that the observed hereditary
susceptibility is present in women worldwide, irrespective
of possible population-dependent background risks. Never-
theless, it remains possible that different DNA polymor-
phisms are responsible for the increased risk of POP
among women of different ethnic descent.
In total eight studies could be used for the meta-analysis.
Since these are all the studies available at the moment, we
feel that we are drawing our conclusions on the best avail-
able evidence. Moreover, all studies point in the same di-
rection, which makes it unlikely that additional research will
alter our results drastically.
As can be seen in Table 1, baseline characteristics of the
studies were not totally similar. In most studies, the mean
parity was 1 to 2. However, the women in the POP group of
the study of Rodrigues et al. had a mean of 4.5 deliveries.
Besides, in some studies the women included were clearly
younger than in other studies. Of course, this also had its
influence on menopausal status.
Likewise, the design of the studies was not always iden-
tical; five of the eight studies were case-control studies,
whereas the other three were cohort studies. Furthermore,
the definition of the POP and control groups differed be-
tween studies.
Regarding the statistics used, we found no statistical
heterogeneity between the studies (I200; p00.47, χ2 for
heterogeneity); therefore, the pooled OR is presented.
As already said, the studies were not homogeneous re-
garding their definition of POP. Most studies used anatom-
ical landmarks to divide women into case and control
groups. Some however chose more strict criteria, e.g. only
included women with POP-Q stage III or IV urogenital
prolapse in the case group and women with POP-Q stage
0 or I in the control group [8]. It seems plausible that by
applying more strict criteria, the difference in prevalence of
positive family history between groups would be more
pronounced. However, this was not depicted in our meta-
analysis.
Three studies [7, 24, 33] used questionnaires to define the
presence or absence of POP. Symptoms of POP, however,
do not always fully correspond to the existence of anatom-
ical POP. For example, in the study of Samuelsson et al. [11]
10 % of the women with POP reported a “sense of heaviness
in the lower abdomen” compared to 8 % of the women
without anatomical POP, a difference that was not statisti-
cally significant. Barber et al. [44] performed a study to
identify the symptoms that most accurately predicted the
presence or absence of POP. They found that the question
“Do you usually have a bulge or something falling out that
you can see or feel in your vaginal area” had the best
discriminative capability. The study of Tan et al. [45] con-
firmed that there was a significant relationship between
symptoms of vaginal bulging and POP on gynaecological
examination. The studies by Miedel et al. [33], Sharma et al.
[24] and Slieker-ten Hove et al. [7] used this question for
discriminative purposes and were therefore included in this
review.
The definition of family history also varied between
studies. It is likely that in studies using broader criteria,
more women will report a positive family history. However,
this is likely to be the same for both POP patients and
controls. Therefore, this will not necessarily introduce bias.
Except for three studies [7, 24, 33], all studies were
performed among women visiting an outpatient department
for regular check-up, prolapse complaints or other benign
gynaecological conditions. These results therefore may not
be generalizable to the general population. However, the
results of the two cohort studies conducted in the general
population [7, 33] and the population-based case-control
study [24] show the same results. It seems therefore plausi-
ble that both in low- and high-risk populations positive
family history is an important risk factor for the develop-
ment of POP.
Recall bias might play a role in the differences found
between patients and controls. Because POP patients are
more focused on POP complaints, they may be more aware
of similar complaints in relatives and therefore more often
report a positive family history compared to controls. How-
ever, evidence for recall bias was absent in comparable
studies on family history of myocardial infarction and colo-
rectal cancer [46, 47]. The controls in these studies reported
family history in first- and second-degree relatives as accu-
rately as the patients did.
Finally, regarding possible publication bias, it needs to be
noted that we only used published studies and abstracts for
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our review and meta-analysis. We performed a funnel plot
and found no deviation from a symmetrical shape. Publica-
tion bias seems therefore unlikely.
Authors’ conclusions
This meta-analysis of 8 studies with 1,107 POP patients and
1,941 controls showed that women with POP are substan-
tially more likely to have family members with the same
condition compared to women without POP. This demon-
strates that a positive family history is an important risk
factor for POP. The fact that the uncontrolled studies
showed a high percentage of positive family history in
POP patients further underlines this conclusion. It strength-
ens the hypothesis that genetic predisposition plays an im-
portant role in the development of POP.
This information is important for clinical practice from a
preventive point of view. Although not all known risk
factors for POP may be modifiable, risk factors such as
obesity [2, 10, 12] and heavy physical work [7] are. In
addition, pelvic floor physiotherapy might reduce the risk
of developing POP. Although statistical evidence that (peri-
partum) pelvic floor exercises can decrease the risk of de-
veloping POP later in life is lacking [48], it is known that
pelvic floor muscle function is significantly related to POP
[21]. Furthermore, a recent study showed that pelvic floor
muscle training supervised by a physical therapist leads to
an increased volume of the pubovisceral muscle, a de-
creased hiatal area and an elevated resting position of the
bladder and rectum [49]. This suggests that pelvic floor
physiotherapy can play a role in primary and secondary
prevention of POP and might therefore be of great impor-
tance in women with an increased risk of POP.
Vaginal delivery can have a detrimental effect on pelvic
floor muscle strength and could thus promote POP. Al-
though there are some studies reporting an association be-
tween caesarean section and a reduced prevalence of POP
[50, 51], the preventive value of a primary caesarean section
is unproven. A recent large study [52] did not find a signif-
icant difference between frequency of POP 20 years after
caesarean or vaginal birth. Since a caesarean section is an
invasive procedure with potentially substantial risks for the
mother, we do not advocate this until there is more evidence
of a protective effect available.
In conclusion, we summarized the evidence available on
family history as a risk factor for the development of POP. Our
primary conclusion was that there is a substantially increased
risk for POP in case of a positive family history. This knowl-
edge might influence the way patients with a positive family
history could be treated. From a preventive point of view,
patients could be informed about risk factors and how to try
to avoid them and could be advised to perform pelvic floor
exercises before problems arise. Until now, there is no evidence
that vaginal delivery should be discouraged. On theoretical
grounds, first-line treatment with mesh material might be indi-
cated for patients with positive family history. To the best of our
knowledge, no studies on this topic have been conducted so far,
so this hypothesis should be the subject of future research.
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Appendix 1. Full PubMed literature search terms
(("genetics"[MeSH Terms] OR "genetics"[Subheading] OR
"Genetic Predisposition to Disease"[Mesh] OR genetic* OR
inheritance OR family OR families OR familial OR gene OR
genes OR DNA)) AND ("Pelvic Organ Prolapse"[Mesh] OR
((pelvic OR vaginal OR uterus OR bladder OR rectum OR
rectal OR bowel OR vagina OR urethra OR perineal OR
perineum OR uterine OR cervix OR cervical OR vault OR
cuff OR genital OR urogenital) AND (descent OR prolapse))
OR uterine prolapse OR rectal prolapse OR cystocele OR
rectocele OR enterocele OR proctocele OR sigmoidoceles
OR peritoneocele OR ureterocele OR cystourethrocele OR
cysto-urethrocele OR pelvic floor dysfunction).
Appendix 2. Full Embase literature search terms
exp genetics/ or genetics.fs. or exp genetic predisposition/ or
(genetic* or inheritance or family or families or familial or
gene or genes or DNA ).mp. AND exp pelvic organ prolapse/
or ((pelvic or vaginal or uterus or bladder or rectum or rectal or
bowel or vagina or urethra or perineal or perineum or uterine or
cervix or cervical or vault or cuff or genital or urogenital).mp.
AND (descent or prolapse).mp.) or (uterine prolapse or rectal
prolapse or cystocele or rectocele or enterocele or proctocele or
sigmoidoceles or peritoneocele or ureterocele or cystourethro-
cele or cysto-urethrocele or pelvic floor dysfunction).mp.
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